Human epidermal growth factor receptor-2 (HER2) encoded by oncogene ErbB2, exhibits amplification and over-expression in 20%–30% of breast cancer cases (Gandhi and Das, 2019). This evidence concerns the gene ERBB2 and breast carcinoma.